Areterna LLC
- Biotech or pharma, animal health
- Biotech or pharma, therapeutic R&D
- Synthesis, analytic, diagnostic services
Areterna is an mRNA technology platform company with a mission to democratize mRNA vaccines. We have developed multiple animal vaccine candidates that cost ~$0.50/dose, such as vaccines for Rabies, FIPV and PEDV, and currently seek collaborators to out-license these vaccines and commercialize them. Our core competence is in mRNA design and manufacturing. We can manufacture mRNA/LNP with full QC panels and provide function/efficacy tests in animals. In addition, we manufacture and supply low-cost GMP grade mRNA starting materials, with ISO 9001 certification and DMF filed for selected cap analogs, NTPs and modified NTPs. Our raw materials have been used in >30 clinical programs. The company has ~400 people and over 200 scientists in R&D.
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}